Adavosertib in Recurrent Uterine Serous Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
J. Clin. Oncol 2021 Mar 11;[EPub Ahead of Print], JF Liu, N Xiong, SM Campos, AA Wright, C Krasner, S Schumer, N Horowitz, J Veneris, N Tayob, S Morrissey, G West, R Quinn, UA Matulonis, PA KonstantinopoulosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.